Recent advances in diagnostic techniques offer a rapid and accurate method for identifying nontuberculous mycobacteria species, potentially accelerating the diagnosis and treatment of infections.
Bernd Merkl, MS, MBA
Advertisement
Bernd Merkl is the business unit director for mycobacteria and tuberculosis at Bruker Molecular Diagnostics. With over 25 years of experience in the diagnostic and life sciences industry, Bernd has held leadership positions at companies ranging from start-ups to large organizations.
Articles by Bernd Merkl, MS, MBA
Advertisement
Latest Updated Articles
Nontuberculous mycobacteria: The Complex Diagnostic ChallengePublished: October 1st 2025 | Updated:
Advertisement
Advertisement
